BioSpace News Archive

Pharm Country

Trevi Therapeutics Announces Multiple Late-Breaking Abstracts Accepted for Presentation at Upcoming Medical Conferences on Analysis of Oral Nalbuphine Extended Release

Trevi Therapeutics, Inc. today announced two late-breaking abstracts were accepted for presentation at upcoming fall medical conferences.

August 24, 2022
·
9 min read
Pharm Country

Alvotech to Participate in Two Upcoming Investor Conferences in September 2022

Alvotech, a global biotech company specialized in the development and manufacture of biosimilar medicines for patients worldwide, announced that members of the leadership team will participate in two upcoming investor conferences in September 2022.

August 24, 2022
·
2 min read
Business

Zealand Pharma Appoints Henriette Wennicke as Chief Financial Officer

Zealand Pharma A/S, a biotechnology company focused on the discovery and development of innovative peptide-based medicines, announced the appointment of Henriette Wennicke as Zealand’s Chief Financial Officer starting November 1, 2022.

August 24, 2022
·
4 min read
BioMidwest

Glaukos Licenses Iveena’s Investigational Keratoconus Therapy

iVeena Delivery Systems Inc. has entered into a strategic licensing agreement with Glaukos Corporation that grants Glaukos an exclusive global license to develop and commercialize IVMED-80, a pharmacologic treatment for keratoconus.

August 24, 2022
·
2 min read
Genetown

Elemental Machines Biotech Connect 2022 offers unique insights into the lab of the future

LabOps pioneer Elemental Machines has started registrations for Biotech Connect 2022, a full day event at MassBioHub, where R&D lab leaders will meet in person on September 22 to analyze the changes shaping up scientific discovery in the future.

August 24, 2022
·
1 min read
Bavarian Nordic Enters Supply Agreement with PAHO to Support Access to Monkeypox Vaccines in Latin America and the Caribbean

Bavarian Nordic A/S announced an agreement with the Pan American Health Organization to facilitate equitable access to the Company’s monkeypox vaccine for countries in Latin America and the Caribbean.

August 24, 2022
·
4 min read
SaNOtize Announces $24 Million in Series B Funding to Advance Its Nitric Oxide-Based Therapeutics, Including Nasal Spray for the Treatment and Prevention of COVID-19

SaNOtize Research & Development Corp., a Canadian anti-infective-focused therapeutics company, announced an oversubscribed $24 million Series B funding to advance its nitric oxide-based therapeutics pipeline.

August 24, 2022
·
4 min read
Lone Star Bio

Magellan Healthcare Hosts Free Webinars During Suicide Prevention Awareness Month and Recovery Month in September

Magellan Healthcare Inc., the behavioral and specialty healthcare segment of Magellan Health, Inc., today announced a series of virtual events in support of Suicide Prevention Awareness Month and Recovery Month in September.

August 24, 2022
·
3 min read
Business

BioCardia Enters Agreement with BlueRock Therapeutics to Provide Enabling Catheter Biotherapeutic Delivery Product Candidates for BlueRock’s Cell Therapy to Treat Heart Failure

BioCardia ® , Inc. [Nasdaq: BCDA], today announced that it has entered into an agreement with BlueRock Therapeutics LP for the delivery of BlueRock’s cell therapy product candidates for the treatment of heart failure utilizing BioCardia’s minimally invasive biotherapeutic delivery product candidates.

August 24, 2022
·
3 min read
Business

Biotheryx Announces Appointment of Tracy Lawhon as Chief Development Officer

Biotheryx, Inc. today announced the appointment of Tracy Lawhon, J.D., as Chief Development Officer (CDO).

August 24, 2022
·
3 min read